AGITG CAP lab tour of the Bill Walsh Lab

We recently welcomed members of the Australasian Gastro-Intestinal Trials Group Consumer Advisory Panel (AGITG CAP) to the Bill Walsh Lab, who came to hear from Dr Sarah Hayes on the progress of our lab’s work on the INTEGRATE clinical trial. The INTEGRATE trial, led by Bill Walsh Lab co-head A/Prof Nick Pavlakis, investigates whether a new drug called Regorafenib is effective for the treatment of stomach and oesophageal cancer.

With your help we are making a difference

Please select ‘Bill Walsh Cancer Research’ on the ‘Donate to’ drop down menu.

How to Donate